✦ LIBER ✦

Treatment of advanced hepatocellular carcinoma (HCC) with tamoxifen (TMX). Preliminary results of a randomized double-blind placebo-controlled trial

Book ID: 118567033
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 118 KB
Volume: 21
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)81229-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with tamoxifen in patients wit

Treatment with tamoxifen in patients with advanced hepatocellular carcinoma results a randomized placebo controlled trial

✍ COLL, S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Treatment of hepatocellular carcinoma wi

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

✍ Antoni Castells; Jordi Bruix; Concepció Brú; Carmen Ayuso; Mercè Roca; Loreto Bo 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 547 KB

1243 Octreotide treatment in patients wi

1243 Octreotide treatment in patients with advanced hepatocellular carcinoma: first results of the randomized placebo-controlled double-blind Hector trial

✍ ALLGAIER, H; BECKER, G; OLSCHEWSKI, M; ZAHRINGER, A; BLUM, H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Transarterial embolization (TAE) in pati

Transarterial embolization (TAE) in patients with advanced hepatocellular carcinoma (HCC). Preliminary results of a randomized controlled trial

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Long-acting octreotide versus placebo fo

Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study

✍ Gerhild Becker; Hans-Peter Allgaier; Manfred Olschewski; Andreas Zähringer; Hube 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

Although numerous treatment modalities have been explored in patients with advanced HCC, the therapeutic options are still limited. Somatostatin has been shown to have antimitotic activity in endocrine as well as in a variety of nonendocrine tumors. Expression of somatostatin receptors is found in H

Treatment of depression with onabotulinu

Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial

✍ Finzi, Eric; Rosenthal, Norman E. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 310 KB